StonvexLoading…
StonvexStonvexStonvexCore line items from FRME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $924.79M | $948.01M | $893.89M | $605.01M |
Operating Income | $259.11M | $231.73M | $259.23M | $255.67M |
Net Income | $226.00M | $201.40M | $223.79M | $222.09M |
EPS (Diluted) | $3.88 | $3.41 | $3.73 | $3.81 |
Total Assets | $19.03B | $18.31B | $18.41B | $18.00B |
Total Liabilities | $16.56B | $16.01B | $16.16B | $15.97B |
Cash & Equivalents | $84.16M | $87.62M | $112.65M | $122.59M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 56.95M | 57.97M | 59.42M | 59.17M |